Myeloma Novel Drug Targets and agents
Brazilian Relapsed Refractory Multiple Myeloma Patients Treated with Teclistamab Outside of Clinical Trials as an Expanded Access Program
Fernando V. Pericole, MD, PhD
Hematologist
Hemocentro UNICAMP
Campinas, Sao Paulo, Brazil